Hikma Pharmaceuticals (HKMPY)

PNK: HKMPY · Real-Time Price · USD

52.97

0.00 (0.00%)

At close: Apr 30, 2025, 3:45 PM

Hikma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	3.11B	3.01B	2.86B	2.79B	2.58B	2.56B	2.57B	2.4B	2.32B	2.31B	2.22B	2.13B	2.07B	2.02B	1.94B	1.96B	1.95B	1.61B
Cost of Revenue	1.75B	1.63B	1.55B	1.48B	1.38B	1.35B	1.35B	1.25B	1.17B	1.14B	1.1B	1.07B	1.07B	1.06B	1.02B	1.03B	1B	746M
Gross Profit	1.37B	1.38B	1.31B	1.31B	1.2B	1.21B	1.22B	1.15B	1.15B	1.17B	1.12B	1.06B	1B	956M	915M	928M	950M	867M
Operating Income	585.61M	476M	473M	611.29M	518.29M	558.8M	599.8M	559.2M	553.2M	571.74M	534.74M	466M	428M	399M	336M	395M	401M	353M
Interest Income	7.96M	7.97M	6.97M	5.1M	3.1M	19M	19M	4.93M	8.93M	9.05M	7.05M	17M	38M	45M	49M	45M	46M	45M
Pretax Income	453.32M	366.37M	280.37M	220.88M	233.88M	441.08M	545.08M	597.91M	552.91M	542.56M	494.56M	378M	293M	-697M	-738M	227M	210M	231M
Net Income	357.66M	284.53M	189.53M	146.73M	188.73M	347.61M	422.61M	463.08M	427.08M	517.05M	490.05M	361M	282M	-806M	-843M	166M	155M	176M
Selling & General & Admin	575.99M	694.68M	674.68M	540.07M	536.07M	498.23M	474.23M	461.81M	458.81M	469.19M	456.19M	475M	467M	460M	474M	450M	429M	392M
Research & Development	140.19M	145.32M	148.32M	142.67M	147.67M	153.78M	143.78M	132.66M	135.66M	130.91M	126.91M	142M	147M	121M	121M	156M	150M	73M
Other Expenses	64M	64.99M	-17.01M	-18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	780.19M	903.01M	840.01M	700.74M	683.74M	652.01M	618.01M	594.46M	594.46M	600.1M	583.1M	644M	673M	1.61B	1.6B	656M	694M	591M
Interest Expense	87.56M	86.66M	86.66M	90.15M	79.15M	64.29M	56.29M	54.46M	53.46M	51.36M	52.36M	25M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	120M	236M	231M	221M	197M
Cost & Expenses	-89.7M	2.53B	2.39B	2.18B	2.06B	2B	1.97B	1.84B	1.77B	1.74B	1.68B	1.72B	1.74B	2.67B	2.63B	1.69B	1.69B	1.34B
Income Tax Expense	92.66M	76.86M	88.86M	72.05M	42.05M	94.49M	124.49M	135.82M	126.82M	24.5M	3.5M	65M	56M	103M	101M	58M	52M	53M
Shares Outstanding (Basic)	110.32M	111.88M	55.14M	55.25M	55.06M	56.75M	57.75M	57.75M	57.61M	60.5M	60.57M	60.54M	121M	121M	120M	120.5M	120M	114M
Shares Outstanding (Diluted)	111.52M	111.88M	55.8M	55.5M	55.06M	57M	58.61M	58M	58.31M	60.78M	60.73M	60.78M	121M	121M	120M	120.5M	120M	114M
EPS (Basic)	3.22	3.08	3.44	2.66	3.32	6.06	7.32	8.04	7.24	8.54	8.10	4.52	2.34	-6.72	-7.02	1.38	1.30	1.66
EPS (Diluted)	3.20	3.06	3.40	2.64	3.32	6.02	7.26	7.96	7.16	8.50	8.06	4.50	2.34	-6.72	-7.02	1.38	1.30	1.66
EBITDA	735.86M	641.28M	660.28M	730M	625M	688.2M	769.2M	800.1M	740.1M	698.46M	646.46M	571M	527M	-455.47M	-525.47M	491M	506M	441M
EBIT	539.88M	451.04M	429.04M	374.04M	313.04M	505.37M	601.37M	652.38M	606.38M	593.92M	546.92M	436.37M	400.37M	-574.91M	-659.91M	299.14M	327.14M	353M
Depreciation & Amortization	195.98M	190.25M	190.25M	197.75M	194.75M	182.83M	167.83M	147.73M	133.73M	104.54M	99.54M	107M	99M	115M	125M	113M	105M	88M